đź’Š IBB Rises as Moderna Leads Gains, Tariff Warnings Stir Pharma Watch | Biotech Sector Insights
(IBB) rose 1.0% since Monday, led by Moderna after the company filed a lawsuit. The move comes amid renewed tariff tensions, with Trump floating potential 200% levies on pharmaceutical firms. ARK Invest’s latest stake in Beam Therapeutics further reflects investor interest in biotech plays.